After a subdued start to the year, PE healthcare services investing in Q3 2024 showed early signs of a rebound. Despite a modest dip in deal volume from Q2, with 148 deals announced or closed, investor confidence is slowly returning. Much of the activity focused on...
What a difference a year makes. In the first half of 2024, the MedTech sector showed a notable uptick in M&A activity, with 114 acquisitions valued at $40.3 billion — close to last year’s total. Despite fewer venture rounds, funding remained strong at $9.7...
McDermott + Bull has successfully placed John Wagner as Chief Executive Officer at private equity-backed Advantage. John will be responsible for providing strategic leadership by collaborating with the Board of Directors, executive management team, and private equity...
McDermott + Bull has successfully placed Lisa Henry as Vice President, Clinical and Regulatory at Magenta Medical. Reporting to the CEO, Lisa will lead the clinical and regulatory strategies critical to Magenta’s success. As the first U.S.-based team member, Lisa will...
McDermott + Bull has successfully placed Jarrod Paulsen as Chief Operating Officer at PE-backed (Shore Capital Partners) AA Medical. Jarrod will be responsible for providing operational leadership, overseeing operations, sales, and integrations, while ensuring both...
McDermott + Bull has successfully placed Hussain Rangwala as Chief Technology Officer at Inari Medical. Reporting to the CEO, Hussain will drive the development and execution of innovative R&D strategies, including fostering a culture of innovation, ensuring...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policyOkNo
